Label: AMOXICILLIN capsule

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated January 1, 2024

If you are a consumer or patient please visit this version.

  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use AMOXICILLIN Capsules, Tablets and for Oral Suspension safely and effectively. See full prescribing information for AMOXICILLIN ...
  • Table of Contents
    Table of Contents
  • 1 INDICATIONS AND USAGE
    1.1 Infections of the Ear, Nose, and Throat - Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY beta-lactamase–negative) isolates of - Streptococcusspecies. (α ...
  • 2 DOSAGE AND ADMINISTRATION
    2.1 Dosing for Adult and Pediatric Patients > 3 Months of Age - Treatment should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic or evidence of ...
  • 3 DOSAGE FORMS AND STRENGTHS
    Capsules:250 mg, 500 mg. Each amoxicillin capsule, with yellow opaque cap and body, contains 250 mg or 500 mg amoxicillin as the trihydrate. The 250 mg capsule is imprinted AMOX 250 on one ...
  • 4 CONTRAINDICATIONS
    Amoxicillin is contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin or to other beta-lactam ...
  • 5 WARNINGS AND PRECAUTIONS
    5.1 Anaphylactic Reactions - Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients on penicillin therapy including amoxicillin. Although ...
  • 6 ADVERSE REACTIONS
    The following are discussed in more detail in other sections of the labeling: Anaphylactic reactions - [see Warnings and Precautions (5.1)] CDAD - [see Warnings and Precautions ...
  • 7 DRUG INTERACTIONS
    7.1 Probenecid - Probenecid decreases the renal tubular secretion of amoxicillin. Concurrent use of amoxicillin and probenecid may result in increased and prolonged blood levels of ...
  • 8 USE IN SPECIFIC POPULATIONS
    8.1 Pregnancy - Teratogenic Effects: Pregnancy Category B. Reproduction studies have been performed in mice and rats at doses up to 2000 mg/kg (3 and 6 times the 3 g human dose, based on body ...
  • 10 OVERDOSAGE
    In case of overdosage, discontinue medication, treat symptomatically, and institute supportive measures as required. A prospective study of 51 pediatric patients at a poison-control center ...
  • 11 DESCRIPTION
    Formulations of amoxicillin contain amoxicillin, a semisynthetic antibiotic, an analog of ampicillin, with a broad spectrum of bactericidal activity against many Gram-positive and Gram-negative ...
  • 12 CLINICAL PHARMACOLOGY
    12.1 Mechanism of Action - Amoxicillin is an antibacterial drug - [see Microbiology ( 12.4)]. 12.3 Pharmacokinetics - Absorption: Amoxicillin is stable in the presence of gastric ...
  • 13 NONCLINICAL TOXICOLOGY
    13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility - Long-term studies in animals have not been performed to evaluate carcinogenic potential. Studies to detect mutagenic potential of ...
  • 14 CLINICAL STUDIES
    14.1 - H. pyloriEradication to Reduce the Risk of Duodenal Ulcer Recurrence - Randomized, double-blind clinical studies performed in the United States in patients with - H. pyloriand duodenal ...
  • 15 REFERENCES
    Swanson-Biearman B, Dean BS, Lopez G, Krenzelok EP. The effects of penicillin and cephalosporin ingestions in children less than six years of age. Vet Hum Toxicol. 1988; 30: 66-67.
  • 16 HOW SUPPLIED/STORAGE AND HANDLING
    Amoxicillin Capsules, USP,for oral administration 500 mg amoxicillin as the trihydrate and are supplied as: 500 mg:yellow, opaque, hard gelatin capsules imprinted AMOX 500 on one side and GG ...
  • 17 PATIENT COUNSELING INFORMATION
    Information for Patients - Patients should be advised that amoxicillin may be taken every 8 hours or every 12 hours, depending on the dose prescribed. Patients should be counseled that ...
  • Principal Display Panel
    NDC: 51655-894-52
  • INGREDIENTS AND APPEARANCE
    Product Information